Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 92 peer-reviewed journal articles Updated
Rheumatology

Understanding Cryoglobulinemic Vasculitis

At a Glance

Cryoglobulinemic vasculitis is a rare condition where abnormal blood proteins clump together in cold temperatures, causing inflammation in small blood vessels. It is usually triggered by an underlying issue like Hepatitis C, an autoimmune disease, or a blood disorder.

Receiving a diagnosis of cryoglobulinemic vasculitis (CV) can feel overwhelming, especially because it is a rare condition that many people—including some healthcare providers—may never have encountered. Understanding the mechanics of what is happening in your body is the first step toward regaining a sense of control and preparing for the road ahead.

Understanding the Name

The name of this condition describes exactly what is happening in your body:

  • Cryo-: Related to cold.
  • -globulin: A type of protein in your blood (immunoglobulins or antibodies).
  • Vasculitis: Inflammation of the blood vessels [1].

In simple terms, CV occurs because certain proteins in your blood, called cryoglobulins, have the unusual property of clumping together or “precipitating” when they are exposed to cold temperatures [2][3]. While this clumping is reversible when the body warms up, the presence of these clumps can trigger a cascade of inflammation that damages the walls of your blood vessels [2][4].

Why It Happens: The Immune Complex

In a healthy immune system, antibodies circulate freely to fight infection. In CV, these antibodies (specifically IgG and IgM) bind together to form immune complexes [5][6].

When these complexes clump together—either because of cold or due to their high concentration—they settle into the lining of small blood vessels, such as the capillaries and venules in your skin, kidneys, and nerves [5][7]. This “traffic jam” of proteins alerts your immune system to attack the area, leading to the inflammation known as vasculitis [1][7]. This process often uses up “complement proteins,” which are part of your immune system’s alarm kit; this is why doctors often find low levels of a protein called C4 in your blood tests [8][9].

A “Secondary” Condition

It is helpful to think of cryoglobulinemic vasculitis not as a random event, but often as a signal that something else is happening in the body. In most cases, CV is a “secondary” disease, meaning it is triggered by an underlying condition that causes the immune system to overproduce these proteins [10][11].

Common “drivers” of CV include:

  • Infections: Historically, the Hepatitis C virus (HCV) has been the most common cause, linked to up to 90% of mixed cryoglobulinemia cases [12][13].
  • Autoimmune Diseases: Conditions like Sjögren’s syndrome or Systemic Lupus Erythematosus (SLE) can cause the body to produce cryoglobulins [14][15].
  • Blood Disorders: Certain B-cell or plasma cell disorders (like multiple myeloma or Waldenström macroglobulinemia) can lead to the production of a single type of “monoclonal” cryoglobulin [16][17].

Living with a Rare Disease

Because CV is a rare disease, the path to diagnosis can often be long and frustrating [18]. You may have experienced “invisible” symptoms or skin rashes that were initially dismissed. It is normal to feel a mix of relief at finally having a name for your symptoms and anxiety about what the diagnosis means for your future.

Current medical guidelines emphasize that treatment should focus on two goals: quieting the immediate inflammation (the vasculitis) and treating the underlying cause (the “driver”) [19][11]. Identifying which type of cryoglobulinemia you have is a critical step your medical team will take to tailor your care [2][20].

Type Composition Common Associations
Type I A single type of antibody (monoclonal) Blood/Bone marrow disorders [16]
Type II A mix of antibodies (monoclonal + polyclonal) Hepatitis C, Autoimmune diseases [12]
Type III All polyclonal antibodies Chronic infections, Autoimmune diseases [14]

If you are just beginning to navigate your care, review our guide on Recognizing Symptoms and Warning Signs and learn how to understand your lab results and biopsies.

In this guide

5 chapters

01

Symptoms and Organ Involvement

Learn the common symptoms of cryoglobulinemic vasculitis (CV). Understand Meltzer's Triad, skin purpura, peripheral neuropathy, and critical warning signs.

02

The 3 Types and Their Causes

Learn the 3 types of cryoglobulinemic vasculitis (Type I, II, III) and their underlying causes. Understand how Hepatitis C and blood disorders trigger CV.

03

Diagnostic Tests and Biopsies

Learn about diagnostic tests and biopsies for cryoglobulinemic vasculitis (CV). Understand warm blood draws, cryocrit, C4 levels, and pathology terms.

04

Standard of Care and Treatment Approaches

Learn about standard treatments for cryoglobulinemic vasculitis (CV). Understand direct-acting antivirals, rituximab, plasmapheresis, and infection risks.

05

Survivorship and Long-term Monitoring

Learn about long-term monitoring and survivorship for cryoglobulinemic vasculitis. Understand kidney health, lymphoma screening, and preventing CV flares.

Common questions in this guide

What causes cryoglobulinemic vasculitis?
Cryoglobulinemic vasculitis is usually triggered by an underlying condition that causes the immune system to overproduce abnormal proteins. The most common cause is the Hepatitis C virus, but autoimmune diseases and certain blood disorders can also drive the disease.
Why do symptoms get worse in the cold?
The condition involves abnormal blood proteins called cryoglobulins that clump together when exposed to cold temperatures. This clumping causes a 'traffic jam' in small blood vessels, triggering the immune system to attack the area and cause inflammation.
What are the different types of cryoglobulinemia?
There are three types of cryoglobulinemia, categorized by the makeup of the abnormal antibodies. Type I is linked to blood disorders, while Types II and III are typically associated with chronic infections like Hepatitis C or autoimmune conditions.
What does a low C4 level mean in my blood test?
C4 is a complement protein that acts as part of your immune system's alarm system. When abnormal proteins clump in your blood vessels and cause inflammation, the body uses up its supply of C4, resulting in lower levels on your lab reports.
What symptoms should I watch out for with cryoglobulinemic vasculitis?
You should monitor for skin rashes, joint pain, fatigue, and numbness that may worsen in the cold. Additionally, watch for signs of nerve or kidney involvement, such as weakness in your hands and feet or foamy, bubbly urine.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What type of cryoglobulinemia do I have (Type I, II, or III), and how does that influence my treatment plan?
  2. 2.Has an underlying cause for my cryoglobulinemia been identified, such as an infection, autoimmune condition, or blood disorder?
  3. 3.What is the current level of my complement proteins, specifically C4, and how will we monitor this over time?
  4. 4.Does our medical center have experience treating rare small-vessel vasculitis, or should I consult with a specialized vasculitis center?
  5. 5.What specific symptoms should I watch for that might indicate the disease is affecting my kidneys or nerves?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Expert perspectives on pathological findings in vasculitis.

    Ishizu A, Kawakami T, Kanno H, et al.

    Modern rheumatology 2023; (33(1)):1-11 doi:10.1093/mr/roac043.

    PMID: 35535676
  2. 2

    Cryoglobulin Test and Cryoglobulinemia Hepatitis C-Virus Related.

    Gulli F, Santini SA, Napodano C, et al.

    Mediterranean journal of hematology and infectious diseases 2017; (9(1)):e2017007 doi:10.4084/MJHID.2017.007.

    PMID: 28101312
  3. 3

    Unusual Morphological and Automated Hematology Analyzer Features in 3 Cases of B-cell Malignancy-associated Type I Cryoglobulinemic Vasculitis.

    Dave RG, Padiyar S, Mathew J, Nair SC

    Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2021; (37(4)):658-663 doi:10.1007/s12288-021-01398-w.

    PMID: 34744348
  4. 4

    Waldenström's Macroglobulinemia and Cryoglobulinemic Glomerulonephritis: An Unusual Case of Monoclonal Gammopathy of Renal Significance.

    De La Flor JC, Sulca JM, Rodríguez P, et al.

    Medical sciences (Basel, Switzerland) 2023; (11(4)) doi:10.3390/medsci11040077.

    PMID: 38132918
  5. 5

    Acrally distributed dermatoses: Vascular dermatoses (purpura and vasculitis).

    Kazandjieva J, Antonov D, Kamarashev J, Tsankov N

    Clinics in dermatology 2017; (35(1)):68-80 doi:10.1016/j.clindermatol.2016.09.013.

    PMID: 27938815
  6. 6

    Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis.

    Dammacco F, Lauletta G, Russi S, et al.

    Clinical and experimental medicine 2019; (19(1)):1-21 doi:10.1007/s10238-018-0536-z.

    PMID: 30430284
  7. 7

    [Cryoglobulinemic vasculitis].

    Iusova OI, Krivosheev OG, Semenkova EN, Kogan EA

    Arkhiv patologii 2000; (62(4)):51-4.

    PMID: 10971876
  8. 8

    The Complement System and C1q in Chronic Hepatitis C Virus Infection and Mixed Cryoglobulinemia.

    El-Shamy A, Branch AD, Schiano TD, Gorevic PD

    Frontiers in immunology 2018; (9()):1001 doi:10.3389/fimmu.2018.01001.

    PMID: 29910796
  9. 9

    Recurrent Mixed Cryoglobulinemia (MCS): A Case Report and Literature Review.

    Bhattarai M, Woytowitz DV, Kaldash H, et al.

    Rhode Island medical journal (2013) 2015; (98(10)):33-7.

    PMID: 26422544
  10. 10

    Cryoglobulinemia: An update in 2019.

    Desbois AC, Cacoub P, Saadoun D

    Joint bone spine 2019; (86(6)):707-713 doi:10.1016/j.jbspin.2019.01.016.

    PMID: 30731128
  11. 11

    Infective Endocarditis Observed With Cryoglobulinemic Vasculitis.

    Liu K, Newman A

    Cureus 2020; (12(9)):e10620 doi:10.7759/cureus.10620.

    PMID: 33123433
  12. 12

    Managing refractory cryoglobulinemic vasculitis: challenges and solutions.

    Ostojic P, Jeremic IR

    Journal of inflammation research 2017; (10()):49-54 doi:10.2147/JIR.S114067.

    PMID: 28507447
  13. 13

    Decline of cellular activation in non-B cells after rituximab treatment in hepatitis C-associated mixed cryoglobulinemia vasculitis.

    Emmanuel B, Sidique N, Zhang X, et al.

    Journal of viral hepatitis 2017; (24(2)):128-131 doi:10.1111/jvh.12618.

    PMID: 27666584
  14. 14

    Cryoglobulinemia in systemic lupus erythematosus: a retrospective study of 213 patients.

    Roubertou Y, Mainbourg S, Hot A, et al.

    Arthritis research & therapy 2022; (24(1)):167 doi:10.1186/s13075-022-02857-z.

    PMID: 35836280
  15. 15

    A Rare Presentation of Cryoglobulinemic Vasculitis Associated with Primary Sjögren's Syndrome.

    Metyas C, Lee JD, Jun JA, Arkfeld DG

    Current rheumatology reviews 2025; (21(4)):480-486 doi:10.2174/0115733971311273240824183333.

    PMID: 39313873
  16. 16

    A multiple myeloma that progressed as type I cryoglobulinemia with skin ulcers and foot necrosis: A case report.

    Solimando AG, Sportelli A, Troiano T, et al.

    Medicine 2018; (97(39)):e12355 doi:10.1097/MD.0000000000012355.

    PMID: 30278513
  17. 17

    A Case of IgG1-Lambda Multiple Myeloma With Hyperviscosity Syndrome and Cryoglobulinemia: Identification of the Subclass Fraction by Immunoelectrophoresis and Immunofixation Electrophoresis.

    Tazoe K, Harada N, Takemura K, et al.

    Cureus 2023; (15(11)):e48253 doi:10.7759/cureus.48253.

    PMID: 38054160
  18. 18

    Non-infectious mixed cryoglobulinemia as a new clinical presentation of mutation in the gene encoding coatomer subunit alpha: a case report of two adult sisters.

    Leśniak K, Płoski R, Rydzanicz M, et al.

    Frontiers in immunology 2024; (15()):1450048 doi:10.3389/fimmu.2024.1450048.

    PMID: 39620212
  19. 19

    Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC).

    Quartuccio L, Bortoluzzi A, Scirè CA, et al.

    Clinical rheumatology 2023; (42(2)):359-370 doi:10.1007/s10067-022-06391-w.

    PMID: 36169798
  20. 20

    New insights in cryoglobulinemic vasculitis.

    Silva F, Pinto C, Barbosa A, et al.

    Journal of autoimmunity 2019; (105()):102313 doi:10.1016/j.jaut.2019.102313.

    PMID: 31383568

This page provides an overview of cryoglobulinemic vasculitis for educational purposes only. Always consult your rheumatologist or specialist for a proper diagnosis and personalized care plan.

Get notified when new evidence is published on Cryoglobulinemic vasculitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.